Next Article in Journal
Alleviation of Memory Deficit by Bergenin via the Regulation of Reelin and Nrf-2/NF-κB Pathway in Transgenic Mouse Model
Previous Article in Journal
An FYVE-Domain-Containing Protein, PsFP1, Is Involved in Vegetative Growth, Oxidative Stress Response and Virulence of Phytophthora sojae
Previous Article in Special Issue
Mercury Chloride but Not Lead Acetate Causes Apoptotic Cell Death in Human Lung Fibroblast MRC5 Cells via Regulation of Cell Cycle Progression
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Erythrocytes as a Model for Heavy Metal-Related Vascular Dysfunction: The Protective Effect of Dietary Components

1
Department of Precision Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
2
Department of Experimental Medicine, Division of Pharmacology, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(12), 6604; https://doi.org/10.3390/ijms22126604
Submission received: 27 May 2021 / Revised: 16 June 2021 / Accepted: 18 June 2021 / Published: 20 June 2021
(This article belongs to the Special Issue Heavy Metal Toxicity in Humans)

Abstract

:
Heavy metals are toxic environmental pollutants associated with severe ecological and human health risks. Among them is mercury (Hg), widespread in air, soil, and water, due to its peculiar geo-biochemical cycle. The clinical consequences of Hg exposure include neurotoxicity and nephrotoxicity. Furthermore, increased risk for cardiovascular diseases is also reported due to a direct effect on cardiovascular tissues, including endothelial cells, recently identified as important targets for the harmful action of heavy metals. In this review, we will discuss the rationale for the potential use of erythrocytes as a surrogate model to study Hg-related toxicity on the cardiovascular system. The toxic effects of Hg on erythrocytes have been amply investigated in the last few years. Among the observed alterations, phosphatidylserine exposure has been proposed as an underlying mechanism responsible for Hg-induced increased proatherogenic and prothrombotic activity of these cells. Furthermore, following Hg-exposure, a decrease in NOS activity has also been reported, with consequent lowering of NO bioavailability, thus impairing endothelial function. An additional mechanism that may induce a decrease in NO availability is the generation of an oxidative microenvironment. Finally, considering that chronic Hg exposure mainly occurs through contaminated foods, the protective effect of dietary components is also discussed.

1. Introduction

Heavy metals are a group of ubiquitous and non-biodegradable pollutants widely distributed in the environment. Heavy metal pollution of the environment results not only from natural sources such as volcanic activity and fossil fuels, but also from numerous agricultural, medical, industrial, and technological human activities [1,2]. Exposure to heavy metals in humans occurs mainly from contamination of water, soil, and food. The exposure to low levels of heavy metals in the general population is widely recognized while massive exposure affects specific subpopulations under certain circumstances, especially occupational ones. Exposure to heavy metals is associated with both short-term adverse effects and long-term diseases such as cancers, immune system dysfunctions, neurocognitive impairments, behavioral abnormalities, hormonal and metabolic dysregulation, and specific organ damage [3,4,5].
It should be emphasized that living systems interact in the environment not only with a single heavy metal [6,7,8,9] but more often with a cocktail of compounds that can have synergistic adverse effects on the organism [10,11,12,13]. Preclinical and clinical studies have investigated the toxicity of mixtures of the main heavy metals [14] that pollute the environment such as lead, mercury (Hg), chromium, cadmium, and arsenic on various organs, systems, or conditions [15,16,17,18,19]. A close association has been reported with immune system dysfunctions [20], bladder cancer [21], neurotoxicity [22,23], and embryogenesis defects [24]. Although the toxicity mechanisms associated with heavy metals are still poorly understood, common mechanisms underlying their toxicity both as single entities or mixtures have been identified [25,26,27,28]. Reactive oxygen species (ROS) production and oxidative stress (OS) are major mechanisms leading to protein alteration, lipid peroxidation, and DNA damage [29,30,31]. Among the various heavy metals, Hg has drawn particular attention, as it is a major environmental pollutant whose levels have been continuously increasing in recent decades due to its increased release in the environment by industrial waste or fuel extraction procedures [32]. Noteworthy is the fact that Hg has been ranked among the 10 chemicals of greatest concern for human health risk by the World Health Organization (WHO) [33].

2. Mercury Exposure and Toxicity

The global burden of Hg toxicity represents a serious public health concern worldwide. Hg exists in the ecosystem in elementary, inorganic, and organic forms. Elemental mercury (Hg0) is liquid and volatile at room temperature. This metal also exists as mercurous (Hg+) and mercuric (Hg2+) cation and can form both inorganic and organic compounds, methylmercury (MeHg) being the most widespread organic compound in the environment and the most important biologically [33,34]. MeHg is readily absorbed by the human body, which does not have an active excretion system for this element.
The different Hg molecular species can be environmentally as well as biologically converted into each other in soil, water, and air, due to their peculiar geo-biochemical cycle (Figure 1) as well as in our body. In aquatic sediments, a small fraction of Hg2+ is converted to organic forms by several kinds of anaerobic microorganisms which [35] enter the food chain through the contamination of fish and shellfish. Here Hg undergoes a process of bioaccumulation and biomagnification along the aquatic food chain until it reaches humans [36]. Conversely, Hg inhaled in elemental form or introduced orally in the form of MeHg, undergoes oxidation by catalase or demethylation in the liver [37,38]. Of the various sources of mercury contamination, food is certainly the most important in the general population. Other sources of contact with mercury affecting a wider range of individuals may be thermometers, batteries and some types of vaccines [39], which are responsible for possible accidental intoxications [40]. Although Hg0 and inorganic compounds are potentially dangerous to human health, exposure to these forms is generally limited to individual occupational exposure. However, Hg0 can be released from dental amalgams, thus representing one of the main sources of chronic exposure to low levels of Hg in humans [41,42].
The molecular mechanisms underlying Hg-induced cytotoxicity are complex, with likely contributions from genetic susceptibility [43] and exposure to the different molecular forms of this metal.
This metal, endowed with a high binding capacity to the sulfhydryl (SH) group, reacts with small molecular weight thiols, including alpha lipoic acid, and glutathione (GSH), thus impairing key metabolic pathways as well as the antioxidant defense system [44,45]. In this respect, Hg binding to selenium-containing proteins inhibits enzymes such as glutathione peroxidase and hinders the restoration of intracellular redox balance, thus worsening OS [46]. Interestingly, the genetic predisposition to the development of antioxidant system dysfunctions is associated with polymorphisms that determine a greater susceptibility to MeHg toxicity [43,47,48]. Specific pathways such as that of thioredoxin are also inhibited by Hg [49,50,51].
In addition, by reacting with crucial cysteine (Cys) residues, Hg may interact with cellular proteins, thus altering and inhibiting their enzymatic and structural functions and potentially leading to severe dysfunction in cellular activities [52]. In particular, Hg inhibitory activity on the glycolytic enzymes hexokinase and phosphofructokinase has been reported [53]. Also, membrane proteins are modified by Hg, including tubulin [54] and erythrocyte (RBC) band 3 and 4.1 and 4.2 proteins [55].
An additional mechanism of Hg toxicity is the induction of mitochondrial dysfunction affecting the activity of F1-F0-ATPase [56], causing oxidative phosphorylation and electron transport defects. This can in turn increase ROS production [57] and redox homeostasis disruption [58]. Furthermore, the carnitine/acylcarnitine transporter has been identified as a possible target of Hg toxicity in mitochondria [59].
Mercury toxicity is also associated with an increase in intracellular Ca2+ due to both an increase in the influx of Ca2+ from the extracellular environment and an increase in the mobilization of intracellular reserves [60]. This effect on calcium homeostasis, associated with the effect of calcium increase due to OS, is responsible for the activation of proteases, lipases, and endonucleases. Figure 2 shows a simplified diagram of the main mechanisms of Hg toxicity.

3. Acute Poisoning and Long-Term Toxicity

The health risk for mankind following Hg exposure has been well documented by a long series of epidemiological and experimental studies. Hg poisoning is usually caused by ingestion or inhalation of its vapors. Acute mercury poisoning can cause various disorders, among which acrodynia is typical [61]. Other manifestations of mercury poisoning are pain in the extremities, neurological disorders such as ataxia, and confusional states (cardiovascular effects such as tachycardia and hypertension), and other non-specific symptoms such as fever, flu-like syndromes, skin rash, nausea, vomiting, and diarrhea [40,62,63]. A delay in treatment can cause serious consequences, such as pneumonitis, renal tubular necrosis and neurological dysfunction [64].
The intoxication by the organic compound MeHg has been associated with the tragedy of Minamata (Japan) in the 50 s. The discharge of this compound in the gulf adjacent to the city caused a serious intoxication of the entire population [65]. The intoxication caused mental disorders, paralysis, coma, and death within a few weeks of the first symptoms [66]. A congenital form of the disease can be transmitted to the fetus during pregnancy causing delayed psychomotor development in infants [67]. This tragic event however has led to a deeper understanding of the mechanisms of MeHg toxicity. Although the mechanism underlying the tissue-selective vulnerability of the central nervous system (CNS) by MeHg remains to be elucidated, post-mortem studies of the above-mentioned mercury intoxication have shown petechial hemorrhages and cerebral edema, suggesting damage to the blood-brain barrier or a general involvement of vascular dysfunction [58,68]. These observations have been confirmed by the finding of a long-term increased incidence of hypertension and myocardial ischemia in the population living in the neighboring areas of Minamata [69].
Numerous studies have shown that long-term exposure to even small amounts of MeHg also affects endothelial function [70,71]. Nowadays, it is widely accepted that Hg exposure may be a risk factor for cerebrovascular and cardiovascular diseases (CVD), even without typical symptoms of Hg intoxication [58,72].

4. Mercury and Endothelial Dysfunction

The correlation between Hg exposure and endothelial dysfunction was confirmed after follow-up studies on severe cases of poisoning, the first being that of Minamata in Japan, which highlighted various cardiovascular anomalies [58,73]. Endothelial cells are very vulnerable to Hg-induced OS caused either by increasing the production of oxidative agents or by inducing a decrease in antioxidant activity [71,74]. The increase of OS induces, via various pathways, endothelial inflammation first and then endothelial dysfunction, ref. [73,75] followed by the development of atherosclerosis, thrombophilia diathesis, and risk of ischemic phenomena through vessel obstruction or vasospastic events [76]. Polymorphisms in genes involved in antioxidant activity in the populations exposed to mercury have been shown to be associated with MeHg retention and increased risk of myocardial infarction [76,77]. Another important mechanism of Hg toxicity on the endothelium is the reduction of nitric oxide (NO) levels [78]. NO is an important cellular signaling molecule, which plays a crucial role in endothelium physiology, synthesized from the amino acid L-arginine by nitric oxide synthase (NOS) isoforms, mainly in endothelial cells [79].
Reduced NO bioavailability, together with the Hg-induced increase in OS, predisposes to CVD, such as carotid atherosclerosis, myocardial infarction, coronary heart disease and hypertension [80,81]. Exposure to low concentrations of Hg in the rat tail artery caused an increase in vascular resistance, mediated by an increase in ROS production, the production of vasoconstrictor mediators and the reduction in the bioavailability of NO [82]. In particular, superoxide anion inactivates NO [83], a potent vasodilator, causing in turn vasoconstriction of arteries [84]. Acute Hg exposure also produced vasoconstriction in rat aortic rings by increasing ROS (via NADPH oxidase) and inhibition of NO production [85]. The chronic exposure to low concentrations of Hg produced similar effects: increased production of ROS, reduced bioavailability of NO and endothelial dysfunction in the mesenteric, coronary, and basilar arteries [82,86]. Hg-induced endothelial damage also involves vasoconstrictor proteinoids derived from the COX-2 pathway and plasma angiotensin-converting enzyme (ACE) [87]. Concomitant mechanisms associated with Hg-induced toxicity are decreased proliferation and migration of endothelial cells, activation of coagulation pathways by promoting platelet aggregation and activation of factor XIII [58]. Hg poisoning is thus associated with the risk of atherothrombotic diseases, including hypertension, cerebrovascular disease, acute myocardial infarction, and renal dysfunction [80,88,89,90,91]. The main organs to be damaged by endothelial dysfunction are therefore the heart, kidneys, and brain [78,80,91]. Vascular dysfunction is also related to the development of hypertension, which exponentially increases the aforementioned risks [90].

5. Mercury and Hypertension

Besides the traditional risk factors associated with hypertension (overweight/obesity, sedentary lifestyle, cigarette smoke and excess salt intake) environmental exposures to heavy metals may also play an important role [92,93]. The most important cohort studies addressed towards the risk of hypertension from Hg exposure are those that were performed on miners or populations particularly exposed to this heavy metal such as Eskimos, inhabitants of the Minamata region, workers and fish consumers. It was observed that Hg miners showed a significant increase in systolic blood pressure which correlated with lipid peroxidation and total OS and an increased risk of developing hypertension of about 50% [94]. Other important studies have shown a close correlation between the Hg content in hair (a marker of Hg exposure) and the incidence of hypertension [95,96]. Other studies, in contrast, have correlated hypertension to the blood content of Hg, repeatedly finding a close association between high levels and hypertension [97,98]. In addition to hypertension, Hg exposure is also associated with a reduction in heart rate variability. The latter predisposes to arrhythmias, ventricular fibrillation, sudden cardiac death, angina, myocardial infarction, CVD, and cerebrovascular accidents [99].
One of the main mechanisms through which both acute and chronic Hg intoxication leads to hypertension is the binding of Hg to the sulfhydryl group of S-adenosyl methionine. This bond causes inactivation of the enzyme catecholamine-O-methyl transferase (COMT) which uses S-adenosyl-methionine as a cofactor. Since this enzyme operates the inactivation by O-methylation of adrenaline, noradrenaline, and dopamine [90]. Its inactivation causes an increase in circulating catecholamines and a syndrome like a pheochromocytoma crisis. This syndrome is characterized by malignant hypertension in acute intoxication and increased urinary excretion of catecholamines in chronic Hg intoxication. Another mechanism associated with hypertension is Hg toxicity with regard to the kidney. This metal concentrates in the renal tubules and glomeruli causing proteinuria and renal fibrosis and failure [100]. Renal dysfunction contributes to water and sodium retention and ultimately to hypertension [82,90,91]. In fact, an increased risk of renal failure of 55% was observed in Hg miners compared to the general population [91].

6. The Role of Erythrocytes in Hg-Induced Endothelium Dysfunction

In this context, it is important to highlight the proposed role of RBC in endothelial dysfunction and the risk of CVD. In fact, an increasing body of data has recently been accumulated on the role of these cells in both hemostasis and coagulation. Based on these findings, Weisel et Litvinov [101] defined RBC as “the forgotten actor” in endothelial dysfunction, reviewing how both quantitative and qualitative changes could affect bleeding or thrombosis [101]. Among the observed alterations, phosphatidylserine (PS) exposure at the outside leaflet of the cellular membrane has been proposed as a candidate hallmark of increased proatherogenic and prothrombotic activity of these cells. Specifically, PS exposure facilitates RBC adhesion to the endothelium, contributing to clot formation [102,103]. Furthermore, microvesicles (MVs) formation also leads to increased pro-coagulating events [104]. The key role of extracellular vesicles from RBC in health, coagulopathy and therapy has been recently reviewed [105].
Mammalian RBC are anucleate cells, deformable thanks to the shape of a biconcave disc, also lacking all the intracellular organelles, and thus representing a simplified model for metabolism studies. Moreover, they are deeply sensitive cells and important health markers because they have a highly specialized and organized cell membrane, which interacts with inflammatory oxidizing agents and mediators, leading to a variety of structural changes that readily signal an abnormal situation [106,107]. Late enucleation of erythroblasts in mammals is considered an advantage in the investigation of particular aspects of these cells as it defines a starting point of an average aging process of 120 days until their elimination. Accordingly, RBC have been identified for use as a cellular aging model [108] as well as being markers of OS-related pathologies, including CVD [106,108]. In fact, RBC are particularly advantageous for the study of OS caused by the high tension of oxygen and the highly toxic free radicals derived from it. Interestingly, being endowed with a powerful antioxidant defense machinery, these cells significantly contribute to other blood cells as well as endothelium from the oxidative insult. However, if RBC reach highly inflamed tissues, such as endothelium with atherosclerotic lesions, their behavior shifts from the physiological activity of scavenger to the harmful role of ROS generator, inducing an oxidative microenvironment, thus worsening the endothelial dysfunction. Therefore, the antioxidant status of RBC might represent a marker in CVD [106,109].
Similarly, RBC have been proposed as a model for pharmacological and toxicological studies which explore mechanisms underlying heavy metal toxicity, including Hg. The effect that toxic substances have on these cells is often omitted, underestimating the concept that blood is the major tissue in contact with exogenous molecules. Moreover, blood also acts as a vehicle of substances, which reach all tissues. As far as heavy metal toxicity is concerned, RBC are a preferential site for Hg accumulation, reaching in these cells a concentration 20 times higher than that found in plasma [110].
The direct toxicity effect of Hg on RBC has been amply investigated in the last few years, both in vivo and in vitro. In a recent review, Vianna et al. [111] discuss the available evidence on potential hematological effects of human mercury exposure, including lymphopenia, lymphocytosis, neutrophilia and basophilia. The possible occurrence of anemia associated with Hg exposure has also been reported [111,112], likely due to hemolysis [112,113,114], loss of blood from the direct effect on the gastrointestinal mucosa and apoptosis [112,114]. Similarly to apoptosis of nucleated cells, RBC may undergo programmed cell death, also called eryptosis [115,116]. Interestingly, both eryptosis and apoptosis of nucleated cells share the feature of externalization of PS [117]. This altered membrane asymmetry results in the erythrophagocytosis of aged RBC, thus regulating the life span of circulating mature cells as well as removal of stressed/damaged RBC in pathological situations [118,119].
In recent years, particular attention has been focused on the mechanisms promoting vascular dysfunction and thrombotic events as a consequence of Hg-induced RBC damage (Figure 3). In this respect, workers occupationally exposed to Hg vapor show increased blood concentration of the heavy metal, associated with significant alterations in the coagulation system [120]. Among suggested mechanisms underlying the cardiovascular effects of Hg exposure, alterations of membrane asymmetry, due to PS exposure, enhances RBC adhesion to the endhothelial cells and clot formation. Hg-mediated SH depletion inhibits flippase and activates scramblase, increasing protein adhesion expression on the external surface of the cell and thrombin production [101]. In fact, PS-bearing RBC and MVs provide a binding site for assembling the prothrombinase complex, leading to thrombin generation, thus stimulating the coagulative cascade even at low-dose Hg2+ exposure. Alterations of RBC membrane proteins, leading to changes in cell shape and deformability, were also reported to be pro-thrombotic factors [121]. Changes in RBC shape have indeed been reported after in vitro exposure to this metal [121,122]. The underlying mechanisms are, also in this case, linked to the ability of this metal to bind SH groups. In fact, GSH and metallothionein, rich in free SH groups, have a pivotal role in the maintenance of erythrocyte integrity (e.g., the cytoskeleton) and ionic/energy balance (e.g., Na2+/K+-ATPase) with ATP depletion and increased calcium. These mechanisms lead to increased fragility of the RBC membrane and disruption and MVs liberation [101]. All together, these effects design RBC as an active contributor to the increase in thrombotic events associated with Hg intoxication (Figure 4) [121,123,124].
An additional key mechanism in which a role of RBC in the endothelial dysfunction has been suggested is NO production. Recent data point to RBC as key regulators of vasodilatation in peripheral tissue. These cells express the isoform eNOS and they display the ability to biosynthesize NO under oxygen deprivation, contributing to circulation homeostasis [125,126,127,128]. In this respect, RBC exposure to HgCl2 has been reported to decrease NOS activity, with consequent lowering of NO levels [78,129]. It is important to emphasise that the reported Hg-induced damage to hemoglobin (Hb) may also contribute to the decreased bioavailability of this key vasorelaxant molecule [130,131]. A tetrameric mercurized form of Hb, supposed to be dysfunctional in physiological conformational changes crucial for the oxygenation/deoxygenation process, can be observed after RBC exposure to Hg2+ [55]. As discussed in the introduction, accessible Cys residues represent the preferential site of Hg–protein interaction. It is worth noting, in this respect, that two critical Cys in position 93 of the beta-chains have been identified in Hb as NO ligand, playing a role in Hb-mediated NO release [130]. Consequently, the alteration of Cys-93, following Hg2+ interaction, might impair the Hb-mediated regulation of blood flow, therefore representing one of the physiologically important manifestations of Hg poisoning in these cells, thus in turn affecting the cardiovascular system. As a result, based on these findings, RBC acquired the title of surrogate model for the study of Hg-induced vascular dysfunction with full rights [129,132,133]. Finally, a different mechanism that may induce a decrease in NO availability is the generation of an oxidative microenvironment associated with Hg exposure. Indeed, it is well known that NO production usually decreases following endothelial dysfunction as well as under OS conditions [129,134]. In this context, when intact RBC are exposed in vitro to the presence of micromolar HgCl2 concentrations a dramatic increase in ROS generation is observed. ROS production is a late event and occurs subsequent to a decrease in the antioxidant thiol GSH, which significantly impairs the antioxidant defense system. In addition, an Hg-induced nitrosative stress is also reported [131].

7. Nutritional Aspects of Mercury Toxicity

Hg is a metal that is not essential for nutrition, in that it is not an essential component of our body and is not involved in any metabolic pathway. However, as discussed in the introduction, diet represents one of the most important routes of chronic exposure to Hg in general populations [135]. The greatest risk comes from eating contaminated food, especially fish, which accumulate high Hg content, due to its peculiar biogeochemical cycle. The critical point for fish contamination is Hg cycling in the Aquatic Ecosystems, where this metal is converted into its organic forms, mainly MeHg, by anaerobic microorganisms. This form, in turn, enters the aquatic trophic network via plankton and it tends to accumulate in biota in the passage through small fish, reaching its greatest concentration in carnivorous fish at the top of the food chain [36] due to the so-called process of biomagnification [136]. Importantly, only Hg biomagnifies in the food chain [137]. Following the water cycle, it pollutes surface and groundwater, involving crops, particularly cereals [138,139]. However, while there are foods responsible for Hg absorption in humans, on the other hand, there are foods containing bioactive compounds which are claimed to reduce its harmful health effects. Several naturally derived products have been tested as potential protective agents, either for prevention and/or as treatment against Hg-induced cytotoxicity [140]. In this context, dietary components capable of chelating heavy metals are increasingly being used [141,142] including dietary fibers able to perform Hg chelation during gastric-intestinal transit [143].
In recent years a possible utilization of garlic (Allium sativium L.) as an important detoxifying agent against heavy metal toxicity, including Hg, has been proposed [144]. This spice, indeed, widely used in preparing food as well as nutraceutical products, contains several organosulfur compounds, the most abundant being allicin [145] able to bind directly to Hg. Interestingly, garlic is also rich in selenium, an essential mineral, which hinders Hg toxicity by forming inactive selenium-Hg complexes as well as by preventing ROS-induced cellular damage. It is well known indeed that selenium strengthens the antioxidant defense system [146], being a co-factor of antioxidant enzymes such as glutathione peroxidase [147]. In this respect, as discussed in the introduction, since a key mechanism underlying heavy metal toxicity is the impairment of the antioxidant defense system, vitamin C and E have been tested as potential protective agents [148,149,150]. Furthermore, several phytochemicals with scavenging properties have been proved to actively counteract the heavy metal-induced body burden and cellular biochemical alterations [151], including curcumin [152,153] and epigallocatechin gallate [154].
Finally, several studies have revealed the role of olive oil polyphenols in the prevention of Hg toxicity. There is general agreement, based on a large body of converging evidence, that the antioxidant fraction, including polyphenols, significantly contributes to the health-promoting effect [155,156] of this typical lipidic source of the Mediterranean Diet, a dietary habit associated with a low incidence of several pathologies [157,158], including CVD [159]. Among these compounds, hydroxytyrosol (3,4-dihydroxyphenyl- ethanol; HT) is mainly responsible for the antioxidant properties of this food due to efficient scavenger activity [160]. Besides its well-recognized anti-inflammatory and anticancer properties [161,162], HT ameliorates the harmful effects of toxic agents, including acrylamide [163,164,165] and acrolein [166,167,168] as well as the mycotoxin ochratoxin-A [169]. Moreover, recent data indicate that this dietary component is able to counteract the toxic effects linked to exposure of heavy metals, including Hg. Mohan et al. reported that the ability of HT to promote the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), which in turn elevates GSH levels, is crucial in ameliorating the neurotoxic effect of MeHg [170]. The protective effects of HT on the biochemical alterations induced in intact human RBC, subjected in vitro to treatment with HgCl2, has been recently investigated by our group [122,171]. The reported findings indicate that HT has the potential to modulate cytotoxicity and to counteract the OS induced in RBC by Hg treatment. An additional study also provides experimental evidence of the efficacy of HT in modulating the programmed suicidal death in these anucleate cells, also devoid of mitochondria and thus lacking any mitochondria-mediated apoptotic pathways. Cell preconditioning with an HT optimal dose, prior to exposure to HgCl2, causes a noteworthy decrease in PS-exposing RBC, almost restoring ATP and GSH content [117]. Also of clinical importance is the finding that HT prevents Hg-induced RBC morphological alterations which potentially enhance the procoagulant activity of these cells, resulting in a contributing factor to Hg-related thrombotic events. In recent years nutritional research as well as in vitro studies have focused on the effects of HT in the progression of atherosclerosis including the expression of adhesion molecules [172,173], a key mechanism implicated in plaque formation. Furthermore, HT inhibits in vitro LDL oxidation and counteracts the OS-induced endothelial dysfunction. The reported data on HT protective effects on Hg-induced RBC alterations reveal that prevention of metal toxicity should be regarded as an additional mechanism responsible for the health-promoting potential of this dietary phenol on the cardiovascular system.

8. Conclusions

Human exposure to Hg, in its elementary and molecular forms, may cause severe damage to the entire organism. If massive exposure is a rare event, mostly related to accidents or occupational exposure, chronic intoxication, due to low-level Hg exposure, is becoming a growing insidious concern for a larger portion of the population. In this respect, the pro-oxidant effect of this metal even at low-dose exposure has shifted the focus from a CNS-centred view to a more holistic view of Hg-induced health damage.
In this context, the data discussed in this review point to the involvement of the cardiovascular system as a major target of long-term toxicity, ranging from endothelial dysfunction to pro-coagulative transformation of RBC. Taken together, these effects expose all organs and systems to increased thrombotic risk. Accordingly, anti-vascular endothelial growth factor) monoclonal antibodies have been proposed, in preclinical settings based on the upregulation of these mediators in Hg-induced endothelial dysfunctions. Moreover, the data on the morphological and metabolic alteration in RBC induced by Hg point to the key role of RBC in Hg-related endothelial dysfunction and let us propose potential alternative targets for the prevention of systemic damage induced by this heavy metal.
Chelation therapy remains the therapy of choice in massive exposure to heavy metals, including Hg. The rationale for using thiol-based chelators lies in their ability to form a ring-like complex with the metal, facilitating its renal excretion. Chelation therapy, however, is not without risks since chelator agents are endowed with a degree of toxicity. In addition, the accurate choice of dosage and timing of administration is essential to avoid depletion of essential metals, with consequent worsening of the general condition of the patient.
The possibility of reducing heavy metal toxicity through bioactive dietary components has attracted great interest recently. Since contaminated food is the major source of chronic Hg exposure in the general population, fighting it on the same battlefield is an intriguing challenge. In addition to its primary role of providing adequate quantities of nutrients, a healthy diet is a vital factor in reducing morbidity and mortality from chronic diseases. In this context, fruit and vegetables contain thousands of phytochemicals, endowed with a variety of biological and pharmacological activities, which are able to strengthen biological functions with the aim of promoting human health and reducing the risk of disease. As far as metal toxicity is concerned, nutritional components, including vitamin C and E and selenium have been proved to be protective, representing an attractive tool to help our body to fight off the adverse effects of heavy metals. Moreover, data discussed in this review provide experimental evidence that antioxidant polyphenols, normally present in our diet, especially the Mediterranean, have the potential to modulate Hg toxicity, therefore representing ideal candidates for nutritional/nutraceutical strategies to counteract the clinical outcomes of chronic Hg exposure in humans, particularly related to CVD.

Author Contributions

Conceptualization, C.M.; writing—original draft preparation, R.N. and R.I.; writing—review and editing, C.M.; visualization, E.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ACEAngiotensin-converting enzyme
COMTCatecholamine-O-methyl transferase
CVDCardiovascular diseases
CysCysteine
GSHGlutathione
HbHemoglobin
HgMercury
Hg0Elemental mercury
Hg2+Mercuric
HTHydroxythyrosol
MeHgMethylmercury
MVsMicrovesicles
NONitric oxide
NOSNitric oxide synthase
Nrf2Nuclear factor erythroid 2-related factor 2
OSOxidative stress
PSPhosphatidylserine
RBCErythrocytes
ROSReactive oxygen species
SHSulfhydryl

References

  1. Jadhav, S.H.; Sarkar, S.N.; Patil, R.D.; Tripathi, H.C. Effects of Subchronic Exposure via Drinking Water to a Mixture of Eight Water-Contaminating Metals: A Biochemical and Histopathological Study in Male Rats. Arch. Environ. Contam. Toxicol. 2007, 53, 667–677. [Google Scholar] [CrossRef]
  2. Jadhav, S.H.; Sarkar, S.N.; Aggarwal, M.; Tripathi, H.C. Induction of Oxidative Stress in Erythrocytes of Male Rats Subchronically Exposed to a Mixture of Eight Metals Found as Groundwater Contaminants in Different Parts of India. Arch. Environ. Contam. Toxicol. 2007, 52, 145–151. [Google Scholar] [CrossRef]
  3. Carpenter, D.O.; Arcaro, K.; Spink, D.C. Understanding the Human Health Effects of Chemical Mixtures. Environ. Health Perspect. 2002, 110 (Suppl. 1), 25–42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Pimentel, D.; Cooperstein, S.; Randell, H.; Filiberto, D.; Sorrentino, S.; Kaye, B.; Nicklin, C.; Yagi, J.; Brian, J.; O’Hern, J.; et al. Ecology of Increasing Diseases: Population Growth and Environmental Degradation. Hum. Ecol. Interdiscip. J. 2007, 35, 653–668. [Google Scholar] [CrossRef] [PubMed]
  5. Prüss-Ustün, A.; Vickers, C.; Haefliger, P.; Bertollini, R. Knowns and Unknowns on Burden of Disease Due to Chemicals: A Systematic Review. Environ. Health 2011, 10, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Basile, J.N.; Bloch, M.J. Exposure to Air Pollution Increases the Incidence of Hypertension and Diabetes in Black Women Living in Los Angeles. J. Clin. Hypertens. 2012, 14, 819–820. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Lettieri, G.; Mollo, V.; Ambrosino, A.; Caccavale, F.; Troisi, J.; Febbraio, F.; Piscopo, M. Molecular Effects of Copper on the Reproductive System of Mytilus Galloprovincialis. Mol. Reprod. Dev. 2019. [Google Scholar] [CrossRef]
  8. Naujokas, M.F.; Anderson, B.; Ahsan, H.; Aposhian, H.V.; Graziano, J.H.; Thompson, C.; Suk, W.A. The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem. Environ. Health Perspect. 2013, 121, 295–302. [Google Scholar] [CrossRef]
  9. Tollett, V.D.; Benvenutti, E.L.; Deer, L.A.; Rice, T.M. Differential Toxicity to Cd, Pb, and Cu in Dragonfly Larvae (Insecta: Odonata). Arch. Environ. Contam. Toxicol. 2009, 56, 77–84. [Google Scholar] [CrossRef]
  10. Shargorodsky, J.; Curhan, S.G.; Henderson, E.; Eavey, R.; Curhan, G.C. Heavy Metals Exposure and Hearing Loss in US Adolescents. Arch. Otolaryngol. Head Neck Surg. 2011, 137, 1183–1189. [Google Scholar] [CrossRef] [Green Version]
  11. Wang, G.; Fowler, B.A. Roles of Biomarkers in Evaluating Interactions among Mixtures of Lead, Cadmium and Arsenic. Toxicol. Appl. Pharmacol. 2008, 233, 92–99. [Google Scholar] [CrossRef]
  12. Payne, R.J.; Stevens, C.J.; Dise, N.B.; Gowing, D.J.; Pilkington, M.G.; Phoenix, G.K.; Emmett, B.A.; Ashmore, M.R. Impacts of Atmospheric Pollution on the Plant Communities of British Acid Grasslands. Environ. Pollut. 2011, 159, 2602–2608. [Google Scholar] [CrossRef]
  13. Silva, R.L.B.; Barra, C.M.; Monteiro, T.C.d.N.; Brilhante, O.M. A study of groundwater contamination with organic fuels and potential public health impact in Itaguaí, Rio de Janeiro State, Brazil. Cad. Saude Publica 2002, 18, 1599–1607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Lettieri, G.; D’Agostino, G.; Mele, E.; Cardito, C.; Esposito, R.; Cimmino, A.; Giarra, A.; Trifuoggi, M.; Raimondo, S.; Notari, T.; et al. Discovery of the Involvement in DNA Oxidative Damage of Human Sperm Nuclear Basic Proteins of Healthy Young Men Living in Polluted Areas. Int. J. Mol. Sci. 2020, 21, 4198. [Google Scholar] [CrossRef] [PubMed]
  15. Marsano, F.; Boatti, L.; Ranzato, E.; Cavaletto, M.; Magnelli, V.; Dondero, F.; Viarengo, A. Effects of Mercury on Dictyostelium Discoideum: Proteomics Reveals the Molecular Mechanisms of Physiological Adaptation and Toxicity. J. Proteome Res. 2010, 9, 2839–2854. [Google Scholar] [CrossRef] [PubMed]
  16. Maresca, V.; Lettieri, G.; Sorbo, S.; Piscopo, M.; Basile, A. Biological Responses to Cadmium Stress in Liverwort Conocephalum Conicum (Marchantiales). Int. J. Mol. Sci. 2020, 21, 6485. [Google Scholar] [CrossRef] [PubMed]
  17. Nurchi, V.M.; Djordjevic, A.B.; Crisponi, G.; Alexander, J.; Bjørklund, G.; Aaseth, J. Arsenic Toxicity: Molecular Targets and Therapeutic Agents. Biomolecules 2020, 10, 235. [Google Scholar] [CrossRef] [Green Version]
  18. Balali-Mood, M.; Naseri, K.; Tahergorabi, Z.; Khazdair, M.R.; Sadeghi, M. Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic. Front. Pharmacol. 2021, 12. [Google Scholar] [CrossRef] [PubMed]
  19. Piscopo, M. Seasonal Dependence of Cadmium Molecular Effects on Mytilus Galloprovincialis (Lamarck, 1819) Protamine-like Protein Properties. Mol. Reprod. Dev. 2019, 86, 1418–1429. [Google Scholar] [CrossRef]
  20. Lehmann, I.; Sack, U.; Lehmann, J. Metal Ions Affecting the Immune System. Met. Ions Toxicol. Eff. Interact. Interdepend. 2011, 8, 157–185. [Google Scholar]
  21. Feki-Tounsi, M.; Olmedo, P.; Gil, F.; Khlifi, R.; Mhiri, M.-N.; Rebai, A.; Hamza-Chaffai, A. Cadmium in Blood of Tunisian Men and Risk of Bladder Cancer: Interactions with Arsenic Exposure and Smoking. Environ. Sci. Pollut. Res. Int. 2013, 20, 7204–7213. [Google Scholar] [CrossRef]
  22. Hu, L.; Greer, J.B.; Solo-Gabriele, H.; Fieber, L.A.; Cai, Y. Arsenic Toxicity in the Human Nerve Cell Line SK-N-SH in the Presence of Chromium and Copper. Chemosphere 2013, 91, 1082–1087. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Rai, N.K.; Ashok, A.; Rai, A.; Tripathi, S.; Nagar, G.K.; Mitra, K.; Bandyopadhyay, S. Exposure to As, Cd and Pb-Mixture Impairs Myelin and Axon Development in Rat Brain, Optic Nerve and Retina. Toxicol. Appl. Pharmacol. 2013, 273, 242–258. [Google Scholar] [CrossRef]
  24. Fathallah, S.; Medhioub, M.N.; Kraiem, M.M. Sediment Contact Assay Using the Carpet Shell Clam, Ruditapes decussatus L., Embryos and Larvae for Assessing Contamination Levels of Four Sites in Tunisian Coast. Bull. Environ. Contam. Toxicol. 2013, 90, 611–615. [Google Scholar] [CrossRef]
  25. Alloway, T.P. What Do We Know about the Long-Term Cognitive Effects of Iron-Deficiency Anemia in Infancy? Dev. Med. Child Neurol. 2013, 55, 401–402. [Google Scholar] [CrossRef]
  26. Lettieri, G.; Notariale, R.; Ambrosino, A.; Di Bonito, A.; Giarra, A.; Trifuoggi, M.; Manna, C.; Piscopo, M. Spermatozoa Transcriptional Response and Alterations in PL Proteins Properties after Exposure of Mytilus Galloprovincialis to Mercury. Int. J. Mol. Sci. 2021, 22, 1618. [Google Scholar] [CrossRef]
  27. Dopp, E.; Kligerman, A.D.; Diaz-Bone, R.A. Organoarsenicals. Uptake, Metabolism, and Toxicity. Organomet. Environ. Toxicol. 2010, 7, 231–265. [Google Scholar] [CrossRef]
  28. Maresca, V.; Fusaro, L.; Sorbo, S.; Siciliano, A.; Loppi, S.; Paoli, L.; Monaci, F.; Karam, E.A.; Piscopo, M.; Guida, M.; et al. Functional and Structural Biomarkers to Monitor Heavy Metal Pollution of One of the Most Contaminated Freshwater Sites in Southern Europe. Ecotoxicol. Environ. Saf. 2018, 163, 665–673. [Google Scholar] [CrossRef] [PubMed]
  29. Whittaker, M.H.; Wang, G.; Chen, X.-Q.; Lipsky, M.; Smith, D.; Gwiazda, R.; Fowler, B.A. Exposure to Pb, Cd, and As Mixtures Potentiates the Production of Oxidative Stress Precursors: 30-Day, 90-Day, and 180-Day Drinking Water Studies in Rats. Toxicol. Appl. Pharmacol. 2011, 254, 154–166. [Google Scholar] [CrossRef]
  30. Wu, X.; Cobbina, S.J.; Mao, G.; Xu, H.; Zhang, Z.; Yang, L. A Review of Toxicity and Mechanisms of Individual and Mixtures of Heavy Metals in the Environment. Environ. Sci. Pollut. Res. Int. 2016, 23, 8244–8259. [Google Scholar] [CrossRef]
  31. De Guglielmo, V.; Puoti, R.; Notariale, R.; Maresca, V.; Ausió, J.; Troisi, J.; Verrillo, M.; Basile, A.; Febbraio, F.; Piscopo, M. Alterations in the Properties of Sperm Protamine-like II Protein after Exposure of Mytilus Galloprovincialis (Lamarck 1819) to Sub-Toxic Doses of Cadmium. Ecotoxicol. Environ. Saf. 2019, 169, 600–606. [Google Scholar] [CrossRef] [PubMed]
  32. Bjørklund, G.; Dadar, M.; Mutter, J.; Aaseth, J. The Toxicology of Mercury: Current Research and Emerging Trends. Environ. Res. 2017, 159. [Google Scholar] [CrossRef] [PubMed]
  33. Raj, D.; Maiti, S. Sources, Toxicity, and Remediation of Mercury: An Essence Review. Environ. Monit. Assess. 2019, 191. [Google Scholar] [CrossRef] [PubMed]
  34. Obrist, D.; Kirk, J.L.; Zhang, L.; Sunderland, E.M.; Jiskra, M.; Selin, N.E. A Review of Global Environmental Mercury Processes in Response to Human and Natural Perturbations: Changes of Emissions, Climate, and Land Use. Ambio 2018, 47, 116–140. [Google Scholar] [CrossRef] [Green Version]
  35. Baldi, F. Microbial Transformation of Mercury Species and Their Importance in the Biogeochemical Cycle of Mercury. Met. Ions Biol. Syst. 1997, 34, 213–257. [Google Scholar]
  36. Qiu, Y.-W.; Wang, W.-X. Comparison of Mercury Bioaccumulation between Wild and Mariculture Food Chains from a Subtropical Bay of Southern China. Environ. Geochem. Health 2016, 38, 39–49. [Google Scholar] [CrossRef] [PubMed]
  37. Berglund, M.; Lind, B.; Björnberg, K.A.; Palm, B.; Einarsson, O.; Vahter, M. Inter-Individual Variations of Human Mercury Exposure Biomarkers: A Cross-Sectional Assessment. Environ. Health 2005, 4, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Park, J.-D.; Zheng, W. Human Exposure and Health Effects of Inorganic and Elemental Mercury. J. Prev. Med. Public Health 2012, 45, 344–352. [Google Scholar] [CrossRef] [PubMed]
  39. Clifton, J.C. Mercury Exposure and Public Health. Pediatr. Clin. N. Am. 2007, 54, 237.e1–237.e45. [Google Scholar] [CrossRef]
  40. Kamensky, O.L.; Horton, D.; Kingsley, D.P.; Bridges, C.C. A Case of Accidental Mercury Intoxication. J. Emerg. Med. 2019, 56, 275–278. [Google Scholar] [CrossRef]
  41. Jirau-Colón, H.; González-Parrilla, L.; Martinez-Jiménez, J.; Adam, W.; Jiménez-Velez, B. Rethinking the Dental Amalgam Dilemma: An Integrated Toxicological Approach. Int. J. Environ. Res. Public Health 2019, 16, 1036. [Google Scholar] [CrossRef] [Green Version]
  42. Tibau, A.V.; Grube, B.D. Mercury Contamination from Dental Amalgam. J. Health Pollut. 2019, 9, 190612. [Google Scholar] [CrossRef]
  43. Andreoli, V.; Sprovieri, F. Genetic Aspects of Susceptibility to Mercury Toxicity: An Overview. Int. J. Environ. Res. Public Health 2017, 14, 93. [Google Scholar] [CrossRef] [Green Version]
  44. Hernández, L.E.; Sobrino-Plata, J.; Montero-Palmero, M.B.; Carrasco-Gil, S.; Flores-Cáceres, M.L.; Ortega-Villasante, C.; Escobar, C. Contribution of Glutathione to the Control of Cellular Redox Homeostasis under Toxic Metal and Metalloid Stress. J. Exp. Bot. 2015, 66, 2901–2911. [Google Scholar] [CrossRef] [Green Version]
  45. Yang, L.; Zhang, Y.; Wang, F.; Luo, Z.; Guo, S.; Strähle, U. Toxicity of Mercury: Molecular Evidence. Chemosphere 2020, 245, 125586. [Google Scholar] [CrossRef] [PubMed]
  46. Usuki, F.; Fujimura, M. Decreased Plasma Thiol Antioxidant Barrier and Selenoproteins as Potential Biomarkers for Ongoing Methylmercury Intoxication and an Individual Protective Capacity. Arch. Toxicol. 2016, 90, 917–926. [Google Scholar] [CrossRef]
  47. Barcelos, G.R.M.; de Souza, M.F.; de Oliveira, A.Á.S.; Lengert, A.V.H.; de Oliveira, M.T.; Camargo, R.B.D.O.G.; Grotto, D.; Valentini, J.; Garcia, S.C.; Braga, G.Ú.L.; et al. Effects of Genetic Polymorphisms on Antioxidant Status and Concentrations of the Metals in the Blood of Riverside Amazonian Communities Co-Exposed to Hg and Pb. Environ. Res. 2015, 138, 224–232. [Google Scholar] [CrossRef]
  48. Schläwicke Engström, K.; Strömberg, U.; Lundh, T.; Johansson, I.; Vessby, B.; Hallmans, G.; Skerfving, S.; Broberg, K. Genetic Variation in Glutathione-Related Genes and Body Burden of Methylmercury. Environ. Health Perspect. 2008, 116, 734–739. [Google Scholar] [CrossRef] [Green Version]
  49. Carvalho, C.M.L.; Chew, E.-H.; Hashemy, S.I.; Lu, J.; Holmgren, A. Inhibition of the Human Thioredoxin System. A Molecular Mechanism of Mercury Toxicity. J. Biol. Chem. 2008, 283, 11913–11923. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Al Bakheet, S.A.; Attafi, I.M.; Maayah, Z.H.; Abd-Allah, A.R.; Asiri, Y.A.; Korashy, H.M. Effect of Long-Term Human Exposure to Environmental Heavy Metals on the Expression of Detoxification and DNA Repair Genes. Environ. Pollut. 2013, 181, 226–232. [Google Scholar] [CrossRef] [PubMed]
  51. Kirkpatrick, M.; Benoit, J.; Everett, W.; Gibson, J.; Rist, M.; Fredette, N. The Effects of Methylmercury Exposure on Behavior and Biomarkers of Oxidative Stress in Adult Mice. Neurotoxicology 2015, 50, 170–178. [Google Scholar] [CrossRef] [PubMed]
  52. Ynalvez, R.; Gutierrez, J.; Gonzalez-Cantu, H. Mini-Review: Toxicity of Mercury as a Consequence of Enzyme Alteration. Biometals 2016, 29, 781–788. [Google Scholar] [CrossRef] [PubMed]
  53. Ramírez-Bajo, M.J.; de Atauri, P.; Ortega, F.; Westerhoff, H.V.; Gelpí, J.L.; Centelles, J.J.; Cascante, M. Effects of Cadmium and Mercury on the Upper Part of Skeletal Muscle Glycolysis in Mice. PLoS ONE 2014, 9, e80018. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Choi, W.-S.; Kim, S.-J.; Kim, J.S. Inorganic Lead (Pb)- and Mercury (Hg)-Induced Neuronal Cell Death Involves Cytoskeletal Reorganization. Lab. Anim. Res. 2011, 27, 219–225. [Google Scholar] [CrossRef] [Green Version]
  55. Piscopo, M.; Notariale, R.; Tortora, F.; Lettieri, G.; Palumbo, G.; Manna, C. Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes. Molecules 2020, 25, 3278. [Google Scholar] [CrossRef]
  56. Nesci, S.; Trombetti, F.; Pirini, M.; Ventrella, V.; Pagliarani, A. Mercury and Protein Thiols: Stimulation of Mitochondrial F1FO-ATPase and Inhibition of Respiration. Chem. Biol. Interact. 2016, 260, 42–49. [Google Scholar] [CrossRef]
  57. Stohs, S.J.; Bagchi, D. Oxidative Mechanisms in the Toxicity of Metal Ions. Free Radic. Biol. Med. 1995, 18, 321–336. [Google Scholar] [CrossRef] [Green Version]
  58. Takahashi, T.; Shimohata, T. Vascular Dysfunction Induced by Mercury Exposure. Int. J. Mol. Sci. 2019, 20, 2435. [Google Scholar] [CrossRef] [Green Version]
  59. Tonazzi, A.; Giangregorio, N.; Console, L.; Scalise, M.; La Russa, D.; Notaristefano, C.; Brunelli, E.; Barca, D.; Indiveri, C. Mitochondrial Carnitine/Acylcarnitine Transporter, a Novel Target of Mercury Toxicity. Chem. Res. Toxicol. 2015, 28, 1015–1022. [Google Scholar] [CrossRef]
  60. Florea, A.-M.; Büsselberg, D. Toxic Effects of Metals: Modulation of Intracellular Calcium Homeostasis. Mater. Werkst. 2005, 36, 757–760. [Google Scholar] [CrossRef]
  61. Bose-O’Reilly, S.; McCarty, K.M.; Steckling, N.; Lettmeier, B. Mercury Exposure and Children’s Health. Curr. Probl. Pediatr. Adolesc. Health Care 2010, 40, 186–215. [Google Scholar] [CrossRef] [Green Version]
  62. Lerch, M.; Bircher, A.J. Systemically Induced Allergic Exanthem from Mercury. Contact Dermat. 2004, 50, 349–353. [Google Scholar] [CrossRef]
  63. Oz, S.G.; Tozlu, M.; Yalcin, S.S.; Sozen, T.; Guven, G.S. Mercury Vapor Inhalation and Poisoning of a Family. Inhal. Toxicol. 2012, 24, 652–658. [Google Scholar] [CrossRef] [PubMed]
  64. Bernhoft, R.A. Mercury Toxicity and Treatment: A Review of the Literature. J. Environ. Public Health 2012, 2012, 460508. [Google Scholar] [CrossRef]
  65. Eto, K. Pathology of Minamata Disease. Toxicol. Pathol. 1997, 25, 614–623. [Google Scholar] [CrossRef] [Green Version]
  66. Igata, A. Epidemiological and Clinical Features of Minamata Disease. Environ. Res. 1993, 63, 157–169. [Google Scholar] [CrossRef] [PubMed]
  67. Matsumoto, H.; Koya, G.; Takeuchi, T. Fetal Minamata Disease: A Neuropathological Study of Two Cases of Intrauterine Intoxication by a Methyl Mercury Compound. J. Neuropathol. Exp. Neurol. 1965, 24, 563–574. [Google Scholar] [CrossRef] [PubMed]
  68. Winkler, E.A.; Bell, R.D.; Zlokovic, B.V. Central Nervous System Pericytes in Health and Disease. Nat. Neurosci. 2011, 14, 1398–1405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Yorifuji, T.; Kashima, S. Secondary Sex Ratio in Regions Severely Exposed to Methylmercury “Minamata Disease”. Int. Arch. Occup. Environ. Health 2016, 89, 659–665. [Google Scholar] [CrossRef]
  70. Kishimoto, T.; Oguri, T.; Abe, M.; Kajitani, H.; Tada, M. Inhibitory Effect of Methylmercury on Migration and Tube Formation by Cultured Human Vascular Endothelial Cells. Arch. Toxicol. 1995, 69, 357–361. [Google Scholar] [CrossRef]
  71. Rajaee, M.; Sánchez, B.N.; Renne, E.P.; Basu, N. An Investigation of Organic and Inorganic Mercury Exposure and Blood Pressure in a Small-Scale Gold Mining Community in Ghana. Int. J. Environ. Res. Public Health 2015, 12, 10020–10038. [Google Scholar] [CrossRef] [Green Version]
  72. Genchi, G.; Sinicropi, M.S.; Carocci, A.; Lauria, G.; Catalano, A. Mercury Exposure and Heart Diseases. Int. J. Environ. Res. Public Health 2017, 14, 74. [Google Scholar] [CrossRef] [Green Version]
  73. Haybar, H.; Shahrabi, S.; Rezaeeyan, H.; Shirzad, R.; Saki, N. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease. Cardiovasc. Toxicol. 2019, 19, 13–22. [Google Scholar] [CrossRef]
  74. Robitaille, S.; Mailloux, R.J.; Chan, H.M. Methylmercury Alters Glutathione Homeostasis by Inhibiting Glutaredoxin 1 and Enhancing Glutathione Biosynthesis in Cultured Human Astrocytoma Cells. Toxicol. Lett. 2016, 256, 1–10. [Google Scholar] [CrossRef]
  75. Small, H.Y.; Migliarino, S.; Czesnikiewicz-Guzik, M.; Guzik, T.J. Hypertension: Focus on Autoimmunity and Oxidative Stress. Free Radic. Biol. Med. 2018, 125, 104–115. [Google Scholar] [CrossRef] [PubMed]
  76. Vassallo, D.V.; Wiggers, G.A.; Padilha, A.S.; Simões, M.R. Endothelium: A Target for Harmful Actions of Metals. Curr. Hypertens. Rev. 2020, 16, 201–209. [Google Scholar] [CrossRef] [PubMed]
  77. de Oliveira, A.Á.S.; de Souza, M.F.; Lengert, A.V.H.; de Oliveira, M.T.; de Camargo, R.B.O.G.; Braga, G.Ú.L.; de Cólus, I.M.S.; Barbosa, F.; Barcelos, G.R.M. Genetic Polymorphisms in Glutathione (GSH-) Related Genes Affect the Plasmatic Hg/Whole Blood Hg Partitioning and the Distribution between Inorganic and Methylmercury Levels in Plasma Collected from a Fish-Eating Population. BioMed Res. Int. 2014, 2014, e940952. [Google Scholar] [CrossRef]
  78. Omanwar, S.; Fahim, M. Mercury Exposure and Endothelial Dysfunction: An Interplay Between Nitric Oxide and Oxidative Stress. Int. J. Toxicol. 2015, 34, 300–307. [Google Scholar] [CrossRef]
  79. Tousoulis, D.; Kampoli, A.-M.; Tentolouris, C.; Papageorgiou, N.; Stefanadis, C. The Role of Nitric Oxide on Endothelial Function. Curr. Vasc. Pharmacol. 2012, 10, 4–18. [Google Scholar] [CrossRef] [PubMed]
  80. Salonen, J.T.; Seppänen, K.; Lakka, T.A.; Salonen, R.; Kaplan, G.A. Mercury Accumulation and Accelerated Progression of Carotid Atherosclerosis: A Population-Based Prospective 4-Year Follow-up Study in Men in Eastern Finland. Atherosclerosis 2000, 148, 265–273. [Google Scholar] [CrossRef]
  81. Guallar, E.; Sanz-Gallardo, M.I.; van’t Veer, P.; Bode, P.; Aro, A.; Gómez-Aracena, J.; Kark, J.D.; Riemersma, R.A.; Martín-Moreno, J.M.; Kok, F.J.; et al. Mercury, Fish Oils, and the Risk of Myocardial Infarction. N. Engl. J. Med. 2002, 347, 1747–1754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Wiggers, G.A.; Peçanha, F.M.; Briones, A.M.; Pérez-Girón, J.V.; Miguel, M.; Vassallo, D.V.; Cachofeiro, V.; Alonso, M.J.; Salaices, M. Low Mercury Concentrations Cause Oxidative Stress and Endothelial Dysfunction in Conductance and Resistance Arteries. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H1033–H1043. [Google Scholar] [CrossRef]
  83. Rubanyi, G.M.; Vanhoutte, P.M. Superoxide Anions and Hyperoxia Inactivate Endothelium-Derived Relaxing Factor. Am. J. Physiol. 1986, 250, H822–H827. [Google Scholar] [CrossRef]
  84. Katusic, Z.S.; Vanhoutte, P.M. Superoxide Anion Is an Endothelium-Derived Contracting Factor. Am. J. Physiol. 1989, 257, H33–H37. [Google Scholar] [CrossRef]
  85. Lemos, N.B.; Angeli, J.K.; Faria, T.D.O.; Ribeiro Junior, R.F.; Vassallo, D.V.; Padilha, A.S.; Stefanon, I. Low Mercury Concentration Produces Vasoconstriction, Decreases Nitric Oxide Bioavailability and Increases Oxidative Stress in Rat Conductance Artery. PLoS ONE 2012, 7, e49005. [Google Scholar] [CrossRef] [Green Version]
  86. Furieri, L.B.; Fioresi, M.; Junior, R.F.R.; Bartolomé, M.V.; Fernandes, A.A.; Cachofeiro, V.; Lahera, V.; Salaices, M.; Stefanon, I.; Vassallo, D.V. Exposure to Low Mercury Concentration in Vivo Impairs Myocardial Contractile Function. Toxicol. Appl. Pharmacol. 2011, 255, 193–199. [Google Scholar] [CrossRef] [Green Version]
  87. Pecanha, F.M.; Wiggers, G.A.; Briones, A.M.; Perez-Giron, J.V.; Miguel, M.; Garcia-Redondo, A.B.; Vassallo, D.V.; Alonso, M.J.; Salaices, M. The Role of Cyclooxygenase (COX)-2 Derived Prostanoids on Vasoconstrictor Responses to Phenylephrine Is Increased by Exposure to Low Mercury Concentration. J. Physiol. Pharmacol. 2010, 61, 29–36. [Google Scholar]
  88. Houston, M.C. The Role of Mercury and Cadmium Heavy Metals in Vascular Disease, Hypertension, Coronary Heart Disease, and Myocardial Infarction. Altern. Ther. Health Med. 2007, 13, S128–S133. [Google Scholar]
  89. Magos, L.; Sparrow, S.; Snowden, R. The Comparative Renotoxicology of Phenylmercury and Mercuric Chloride. Arch. Toxicol. 1982, 50, 133–139. [Google Scholar] [CrossRef] [PubMed]
  90. Torres, A.D.; Rai, A.N.; Hardiek, M.L. Mercury Intoxication and Arterial Hypertension: Report of Two Patients and Review of the Literature. Pediatrics 2000, 105, E34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  91. Boffetta, P.; Sällsten, G.; Garcia-Gómez, M.; Pompe-Kirn, V.; Zaridze, D.; Bulbulyan, M.; Caballero, J.D.; Ceccarelli, F.; Kobal, A.B.; Merler, E. Mortality from Cardiovascular Diseases and Exposure to Inorganic Mercury. Occup. Environ. Med. 2001, 58, 461–466. [Google Scholar] [CrossRef] [Green Version]
  92. Yorifuji, T.; Tsuda, T.; Kashima, S.; Takao, S.; Harada, M. Long-Term Exposure to Methylmercury and Its Effects on Hypertension in Minamata. Environ. Res. 2010, 110, 40–46. [Google Scholar] [CrossRef]
  93. Houston, M.C. Role of Mercury Toxicity in Hypertension, Cardiovascular Disease, and Stroke. J. Clin. Hypertens. 2011, 13, 621–627. [Google Scholar] [CrossRef] [PubMed]
  94. Kobal, A.B.; Horvat, M.; Prezelj, M.; Briski, A.S.; Krsnik, M.; Dizdarevic, T.; Mazej, D.; Falnoga, I.; Stibilj, V.; Arneric, N.; et al. The Impact of Long-Term Past Exposure to Elemental Mercury on Antioxidative Capacity and Lipid Peroxidation in Mercury Miners. J. Trace Elem. Med. Biol. 2004, 17, 261–274. [Google Scholar] [CrossRef]
  95. Fillion, M.; Mergler, D.; Sousa Passos, C.J.; Larribe, F.; Lemire, M.; Guimarães, J.R.D. A Preliminary Study of Mercury Exposure and Blood Pressure in the Brazilian Amazon. Environ. Health 2006, 5, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Bautista, L.E.; Stein, J.H.; Morgan, B.J.; Stanton, N.; Young, T.; Nieto, F.J. Association of Blood and Hair Mercury with Blood Pressure and Vascular Reactivity. WMJ 2009, 108, 250–252. [Google Scholar] [PubMed]
  97. Pedersen, E.B.; Jørgensen, M.E.; Pedersen, M.B.; Siggaard, C.; Sørensen, T.B.; Mulvad, G.; Hansen, J.C.; Asmund, G.; Skjoldborg, H. Relationship between Mercury in Blood and 24-h Ambulatory Blood Pressure in Greenlanders and Danes. Am. J. Hypertens. 2005, 18, 612–618. [Google Scholar] [CrossRef] [Green Version]
  98. Vupputuri, S.; Longnecker, M.P.; Daniels, J.L.; Guo, X.; Sandler, D.P. Blood Mercury Level and Blood Pressure among US Women: Results from the National Health and Nutrition Examination Survey 1999-2000. Environ. Res. 2005, 97, 195–200. [Google Scholar] [CrossRef]
  99. Valera, B.; Dewailly, E.; Poirier, P. Cardiac Autonomic Activity and Blood Pressure among Nunavik Inuit Adults Exposed to Environmental Mercury: A Cross-Sectional Study. Environ. Health 2008, 7, 29. [Google Scholar] [CrossRef] [Green Version]
  100. Kobal, A.B.; Flisar, Z.; Miklavcic, V.; Dizdarević, T.; Sesek-Briski, A. Renal Function in Miners Intermittently Exposed to Elemental Mercury Vapour. Arh. Hig. Rada Toksikol. 2000, 51, 369–380. [Google Scholar]
  101. Weisel, J.W.; Litvinov, R.I. Red Blood Cells: The Forgotten Player in Hemostasis and Thrombosis. J. Thromb. Haemost. 2019, 17, 271–282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Zwaal, R.F.A.; Comfurius, P.; Van Deenen, L.L.M. Membrane Asymmetry and Blood Coagulation. Nature 1977, 268, 358–360. [Google Scholar] [CrossRef]
  103. Closse, C.; Dachary-Prigent, J.; Boisseau, M.R. Phosphatidylserine-Related Adhesion of Human Erythrocytes to Vascular Endothelium. Br. J. Haematol. 1999, 107, 300–302. [Google Scholar] [CrossRef] [PubMed]
  104. Sudnitsyna, J.; Skverchinskaya, E.; Dobrylko, I.; Nikitina, E.; Gambaryan, S.; Mindukshev, I. Microvesicle Formation Induced by Oxidative Stress in Human Erythrocytes. Antioxidants 2020, 9, 929. [Google Scholar] [CrossRef]
  105. Thangaraju, K.; Neerukonda, S.N.; Katneni, U.; Buehler, P.W. Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy. Int. J. Mol. Sci. 2020, 22, 153. [Google Scholar] [CrossRef] [PubMed]
  106. Massaccesi, L.; Galliera, E.; Corsi Romanelli, M.M. Erythrocytes as Markers of Oxidative Stress Related Pathologies. Mech. Ageing Dev. 2020, 191, 111333. [Google Scholar] [CrossRef]
  107. Hsieh, C.; Prabhu, N.C.S.; Rajashekaraiah, V. Age-Related Modulations in Erythrocytes under Blood Bank Conditions. Transfus. Med. Hemother. 2019, 46, 257–266. [Google Scholar] [CrossRef] [PubMed]
  108. Kaestner, L.; Minetti, G. The Potential of Erythrocytes as Cellular Aging Models. Cell Death Differ. 2017, 24, 1475–1477. [Google Scholar] [CrossRef]
  109. Mohanty, J.G.; Nagababu, E.; Rifkind, J.M. Red Blood Cell Oxidative Stress Impairs Oxygen Delivery and Induces Red Blood Cell Aging. Front. Physiol. 2014, 5, 84. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Zalups, R.K. Molecular Interactions with Mercury in the Kidney. Pharmacol. Rev. 2000, 52, 113–143. [Google Scholar] [PubMed]
  111. Vianna, A.D.S.; Matos, E.P.D.; Jesus, I.M.D.; Asmus, C.I.R.F.; Câmara, V.D.M. Human Exposure to Mercury and Its Hematological Effects: A Systematic Review. Cad. Pública 2019, 35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Zolla, L.; Lupidi, G.; Bellelli, A.; Amiconi, G. Effect of Mercuric Ions on Human Erythrocytes. Relationships between Hypotonic Swelling and Cell Aggregation. Biochim. Biophys. Acta 1997, 1328, 273–280. [Google Scholar] [CrossRef] [Green Version]
  113. De Palma, G.; Mariotti, O.; Lonati, D.; Goldoni, M.; Catalani, S.; Mutti, A.; Locatelli, C.; Apostoli, P. Toxicokinetics and Toxicodynamics of Elemental Mercury Following Self-Administration. Clin. Toxicol. 2008, 46, 869–876. [Google Scholar] [CrossRef] [Green Version]
  114. Suwalsky, M.; Ungerer, B.; Villena, F.; Cuevas, F.; Sotomayor, C.P. HgCl2 Disrupts the Structure of the Human Erythrocyte Membrane and Model Phospholipid Bilayers. J. Inorg. Biochem. 2000, 81, 267–273. [Google Scholar] [CrossRef]
  115. Lang, F.; Lang, K.S.; Lang, P.A.; Huber, S.M.; Wieder, T. Mechanisms and Significance of Eryptosis. Antioxid. Redox Signal. 2006, 8, 1183–1192. [Google Scholar] [CrossRef] [PubMed]
  116. Tortora, F.; Notariale, R.; Lang, F.; Manna, C. Hydroxytyrosol Decreases Phosphatidylserine Exposure and Inhibits Suicidal Death Induced by Lysophosphatidic Acid in Human Erythrocytes. Cell Physiol. Biochem. 2019, 53, 921–932. [Google Scholar] [CrossRef] [Green Version]
  117. Officioso, A.; Alzoubi, K.; Lang, F.; Manna, C. Hydroxytyrosol Inhibits Phosphatidylserine Exposure and Suicidal Death Induced by Mercury in Human Erythrocytes: Possible Involvement of the Glutathione Pathway. Food Chem. Toxicol. 2016, 89, 47–53. [Google Scholar] [CrossRef]
  118. Gottlieb, Y.; Topaz, O.; Cohen, L.A.; Yakov, L.D.; Haber, T.; Morgenstern, A.; Weiss, A.; Chait Berman, K.; Fibach, E.; Meyron-Holtz, E.G. Physiologically Aged Red Blood Cells Undergo Erythrophagocytosis in Vivo but Not in Vitro. Haematologica 2012, 97, 994–1002. [Google Scholar] [CrossRef] [Green Version]
  119. Arashiki, N.; Takakuwa, Y. Maintenance and Regulation of Asymmetric Phospholipid Distribution in Human Erythrocyte Membranes: Implications for Erythrocyte Functions. Curr. Opin. Hematol. 2017, 24, 167–172. [Google Scholar] [CrossRef] [PubMed]
  120. Wierzbicki, R.; Prażanowski, M.; Michalska, M.; Krajewska, U.; Mielicki, W.P. Disorders in Blood Coagulation in Humans Occupationally Exposed to Mercuric Vapors. J. Trace Elem. Exp. Med. 2002, 15, 21–29. [Google Scholar] [CrossRef]
  121. Lim, K.-M.; Kim, S.; Noh, J.-Y.; Kim, K.; Jang, W.-H.; Bae, O.-N.; Chung, S.-M.; Chung, J.-H. Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease. Environ. Health Perspect. 2010, 118, 928–935. [Google Scholar] [CrossRef] [Green Version]
  122. Tagliafierro, L.; Officioso, A.; Sorbo, S.; Basile, A.; Manna, C. The Protective Role of Olive Oil Hydroxytyrosol against Oxidative Alterations Induced by Mercury in Human Erythrocytes. Food Chem. Toxicol. 2015, 82, 59–63. [Google Scholar] [CrossRef] [PubMed]
  123. Eisele, K.; Lang, P.A.; Kempe, D.S.; Klarl, B.A.; Niemöller, O.; Wieder, T.; Huber, S.M.; Duranton, C.; Lang, F. Stimulation of Erythrocyte Phosphatidylserine Exposure by Mercury Ions. Toxicol. Appl. Pharmacol. 2006, 210, 116–122. [Google Scholar] [CrossRef]
  124. Maseko, P.B.; van Rooy, M.; Taute, H.; Venter, C.; Serem, J.C.; Oberholzer, H.M. Whole Blood Ultrastructural Alterations by Mercury, Nickel and Manganese Alone and in Combination: An Ex Vivo Investigation. Toxicol. Ind. Health 2021, 37, 98–111. [Google Scholar] [CrossRef]
  125. Chen, L.Y.; Mehta, J.L. Evidence for the Presence of L-Arginine-Nitric Oxide Pathway in Human Red Blood Cells: Relevance in the Effects of Red Blood Cells on Platelet Function. J. Cardiovasc. Pharmacol. 1998, 32, 57–61. [Google Scholar] [CrossRef]
  126. Kang, E.S.; Ford, K.; Grokulsky, G.; Wang, Y.B.; Chiang, T.M.; Acchiardo, S.R. Normal Circulating Adult Human Red Blood Cells Contain Inactive NOS Proteins. J. Lab. Clin. Med. 2000, 135, 444–451. [Google Scholar] [CrossRef] [PubMed]
  127. Bhattacharya, S.; Chakraborty Patra, S.; Basu Roy, S.; Kahn, N.N.; Sinha, A.K. Purification and Properties of Insulin-Activated Nitric Oxide Synthase from Human Erythrocyte Membranes. Arch. Physiol. Biochem. 2001, 109, 441–449. [Google Scholar] [CrossRef] [PubMed]
  128. Kleinbongard, P.; Dejam, A.; Lauer, T.; Rassaf, T.; Schindler, A.; Picker, O.; Scheeren, T.; Gödecke, A.; Schrader, J.; Schulz, R.; et al. Plasma Nitrite Reflects Constitutive Nitric Oxide Synthase Activity in Mammals. Free Radic. Biol. Med. 2003, 35, 790–796. [Google Scholar] [CrossRef]
  129. Harisa, G.I.; Mariee, A.D.; Abo-Salem, O.M.; Attiaa, S.M. Erythrocyte Nitric Oxide Synthase as a Surrogate Marker for Mercury-Induced Vascular Damage: The Modulatory Effects of Naringin. Environ. Toxicol. 2014, 29, 1314–1322. [Google Scholar] [CrossRef]
  130. Gladwin, M.T.; Lancaster, J.R.; Freeman, B.A.; Schechter, A.N. Nitric Oxide’s Reactions with Hemoglobin: A View through the SNO-Storm. Nat. Med. 2003, 9, 496–500. [Google Scholar] [CrossRef] [PubMed]
  131. Ahmad, S.; Mahmood, R. Mercury Chloride Toxicity in Human Erythrocytes: Enhanced Generation of ROS and RNS, Hemoglobin Oxidation, Impaired Antioxidant Power, and Inhibition of Plasma Membrane Redox System. Environ. Sci. Pollut. Res. Int. 2019, 26, 5645–5657. [Google Scholar] [CrossRef]
  132. Minetti, M.; Agati, L.; Malorni, W. The Microenvironment Can Shift Erythrocytes from a Friendly to a Harmful Behavior: Pathogenetic Implications for Vascular Diseases. Cardiovasc. Res. 2007, 75, 21–28. [Google Scholar] [CrossRef] [Green Version]
  133. Harisa, G.I.; Alanazi, F.K.; El-Bassat, R.A.; Malik, A.; Abdallah, G.M. Protective Effect of Pravastatin against Mercury Induced Vascular Cells Damage: Erythrocytes as Surrogate Markers. Environ. Toxicol. Pharmacol. 2012, 34, 428–435. [Google Scholar] [CrossRef]
  134. Saravanakumar, M.; Raja, B. Veratric Acid, a Phenolic Acid Attenuates Blood Pressure and Oxidative Stress in L-NAME Induced Hypertensive Rats. Eur. J. Pharmacol. 2011, 671, 87–94. [Google Scholar] [CrossRef]
  135. Nunes, E.; Cavaco, A.; Carvalho, C. Exposure Assessment of Pregnant Portuguese Women to Methylmercury through the Ingestion of Fish: Cross-Sectional Survey and Biomarker Validation. J. Toxicol. Environ. Health A 2014, 77, 133–142. [Google Scholar] [CrossRef] [PubMed]
  136. Yan, H.; Li, Q.; Yuan, Z.; Jin, S.; Jing, M. Research Progress of Mercury Bioaccumulation in the Aquatic Food Chain, China: A Review. Bull. Environ. Contam. Toxicol. 2019, 102, 612–620. [Google Scholar] [CrossRef] [PubMed]
  137. Dsikowitzky, L.; Mengesha, M.; Dadebo, E.; de Carvalho, C.E.V.; Sindern, S. Assessment of Heavy Metals in Water Samples and Tissues of Edible Fish Species from Awassa and Koka Rift Valley Lakes, Ethiopia. Environ. Monit. Assess. 2013, 185, 3117–3131. [Google Scholar] [CrossRef]
  138. Barkay, T.; Poulain, A.J. Mercury (Micro)Biogeochemistry in Polar Environments. FEMS Microbiol. Ecol. 2007, 59, 232–241. [Google Scholar] [CrossRef] [PubMed]
  139. Liu, J.-L.; Xu, X.-R.; Yu, S.; Cheng, H.; Peng, J.-X.; Hong, Y.-G.; Feng, X.-B. Mercury Contamination in Fish and Human Hair from Hainan Island, South China Sea: Implication for Human Exposure. Environ. Res. 2014, 135, 42–47. [Google Scholar] [CrossRef] [PubMed]
  140. Kalender, S.; Uzun, F.G.; Demir, F.; Uzunhisarcıklı, M.; Aslanturk, A. Mercuric Chloride-Induced Testicular Toxicity in Rats and the Protective Role of Sodium Selenite and Vitamin E. Food Chem. Toxicol. 2013, 55, 456–462. [Google Scholar] [CrossRef]
  141. Pal, R.; Rai, J.P.N. Phytochelatins: Peptides Involved in Heavy Metal Detoxification. Appl. Biochem. Biotechnol. 2010, 160, 945–963. [Google Scholar] [CrossRef] [PubMed]
  142. Manini, P.; Panzella, L.; Eidenberger, T.; Giarra, A.; Cerruti, P.; Trifuoggi, M.; Napolitano, A. Efficient Binding of Heavy Metals by Black Sesame Pigment: Toward Innovative Dietary Strategies To Prevent Bioaccumulation. J. Agric. Food Chem. 2016, 64. [Google Scholar] [CrossRef]
  143. Rowland, I.R.; Mallett, A.K.; Flynn, J.; Hargreaves, R.J. The Effect of Various Dietary Fibres on Tissue Concentration and Chemical Form of Mercury after Methylmercury Exposure in Mice. Arch. Toxicol. 1986, 59, 94–98. [Google Scholar] [CrossRef] [PubMed]
  144. Mumtaz, S.; Ali, S.; Khan, R.; Shakir, H.A.; Tahir, H.M.; Mumtaz, S.; Andleeb, S. Therapeutic Role of Garlic and Vitamins C and E against Toxicity Induced by Lead on Various Organs. Environ. Sci. Pollut. Res. Int. 2020, 27, 8953–8964. [Google Scholar] [CrossRef]
  145. Amagase, H.; Petesch, B.L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of Garlic and Its Bioactive Components. J. Nutr. 2001, 131, 955S–962S. [Google Scholar] [CrossRef]
  146. Ralston, N.V.C.; Ralston, C.R.; Raymond, L.J. Selenium Health Benefit Values: Updated Criteria for Mercury Risk Assessments. Biol. Trace Elem. Res. 2016, 171, 262–269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  147. Eb, K. The Importance of Antioxidants Which Play the Role in Cellular Response against Oxidative/Nitrosative Stress: Current State. Nutr. J. 2016, 15. [Google Scholar] [CrossRef] [Green Version]
  148. Rendón-Ramírez, A.; Cerbón-Solórzano, J.; Maldonado-Vega, M.; Quintanar-Escorza, M.; Calderón-Salinas, J. Vitamin-E Reduces the Oxidative Damage on δ-aminolevulinic Dehydratase Induced by Lead Intoxication in Rat Erythrocytes. Toxicol. In Vitro Int. J. Publ. Assoc. BIBRA 2007, 21, 1121–1126. [Google Scholar] [CrossRef]
  149. Figueroa-Méndez, R.; Rivas-Arancibia, S. Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain. Front. Physiol. 2015, 6, 397. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  150. Al-Bideri, A.W. Histopathological Study on the Effect of Antioxidants (Vitamin E and Selenium) in Hepatotoxicity Induced by Lead Acetate in Rats. Qadisiah Med. J. 2011, 7, 142–155. [Google Scholar]
  151. Tortora, F.; Notariale, R.; Maresca, V.; Good, K.V.; Sorbo, S.; Basile, A.; Piscopo, M.; Manna, C. Phenol-Rich Feijoa Sellowiana (Pineapple Guava) Extracts Protect Human Red Blood Cells from Mercury-Induced Cellular Toxicity. Antioxidants 2019, 8, 220. [Google Scholar] [CrossRef] [Green Version]
  152. Mohammad Abu-Taweel, G.; Al-Fifi, Z. Protective Effects of Curcumin towards Anxiety and Depression-like Behaviors Induced Mercury Chloride. Saudi J. Biol. Sci. 2021, 28, 125–134. [Google Scholar] [CrossRef] [PubMed]
  153. Li, S.; Wang, X.; Xiao, Y.; Wang, Y.; Wan, Y.; Li, X.; Li, Q.; Tang, X.; Cai, D.; Ran, B.; et al. Curcumin Ameliorates Mercuric Chloride-Induced Liver Injury via Modulating Cytochrome P450 Signaling and Nrf2/HO-1 Pathway. Ecotoxicol. Environ. Saf. 2021, 208, 111426. [Google Scholar] [CrossRef] [PubMed]
  154. Zwolak, I. Epigallocatechin Gallate for Management of Heavy Metal-Induced Oxidative Stress: Mechanisms of Action, Efficacy, and Concerns. Int. J. Mol. Sci. 2021, 22, 4027. [Google Scholar] [CrossRef] [PubMed]
  155. Castro-Barquero, S.; Tresserra-Rimbau, A.; Vitelli-Storelli, F.; Doménech, M.; Salas-Salvadó, J.; Martín-Sánchez, V.; Rubín-García, M.; Buil-Cosiales, P.; Corella, D.; Fitó, M.; et al. Dietary Polyphenol Intake Is Associated with HDL-Cholesterol and A Better Profile of Other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study. Nutrients 2020, 12, 689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Piscopo, M.; Tenore, G.C.; Notariale, R.; Maresca, V.; Maisto, M.; de Ruberto, F.; Heydari, M.; Sorbo, S.; Basile, A. Antimicrobial and Antioxidant Activity of Proteins from Feijoa Sellowiana Berg. Fruit before and after in Vitro Gastrointestinal Digestion. Nat. Prod. Res. 2019, 34, 2607–2611. [Google Scholar] [CrossRef]
  157. Martinez-Gonzalez, M.A.; Martin-Calvo, N. Mediterranean Diet and Life Expectancy; beyond Olive Oil, Fruits, and Vegetables. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 401–407. [Google Scholar] [CrossRef]
  158. Martínez-González, M.A.; Salas-Salvadó, J.; Estruch, R.; Corella, D.; Fitó, M.; Ros, E.; PREDIMED INVESTIGATORS. Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. Prog. Cardiovasc. Dis. 2015, 58, 50–60. [Google Scholar] [CrossRef] [Green Version]
  159. Martínez-González, M.A.; Gea, A.; Ruiz-Canela, M. The Mediterranean Diet and Cardiovascular Health. Circ. Res. 2019, 124, 779–798. [Google Scholar] [CrossRef]
  160. Gorzynik-Debicka, M.; Przychodzen, P.; Cappello, F.; Kuban-Jankowska, A.; Marino Gammazza, A.; Knap, N.; Wozniak, M.; Gorska-Ponikowska, M. Potential Health Benefits of Olive Oil and Plant Polyphenols. Int. J. Mol. Sci. 2018, 19, 686. [Google Scholar] [CrossRef] [Green Version]
  161. Bertelli, M.; Kiani, A.K.; Paolacci, S.; Manara, E.; Kurti, D.; Dhuli, K.; Bushati, V.; Miertus, J.; Pangallo, D.; Baglivo, M.; et al. Hydroxytyrosol: A Natural Compound with Promising Pharmacological Activities. J. Biotechnol. 2020, 309, 29–33. [Google Scholar] [CrossRef] [PubMed]
  162. Echeverría, F.; Ortiz, M.; Valenzuela, R.; Videla, L.A. Hydroxytyrosol and Cytoprotection: A Projection for Clinical Interventions. Int. J. Mol. Sci. 2017, 18, 930. [Google Scholar] [CrossRef] [PubMed]
  163. Zhang, X.; Cao, J.; Jiang, L.; Geng, C.; Zhong, L. Protective Effect of Hydroxytyrosol against Acrylamide-Induced Cytotoxicity and DNA Damage in HepG2 Cells. Mutat. Res. 2009, 664, 64–68. [Google Scholar] [CrossRef]
  164. Rodríguez-Ramiro, I.; Martín, M.Á.; Ramos, S.; Bravo, L.; Goya, L. Olive Oil Hydroxytyrosol Reduces Toxicity Evoked by Acrylamide in Human Caco-2 Cells by Preventing Oxidative Stress. Toxicology 2011, 288, 43–48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  165. Troise, A.D.; Colantuono, A.; Fiore, A. Spray-Dried Olive Mill Wastewater Reduces Maillard Reaction in Cookies Model System. Food Chem. 2020, 323, 126793. [Google Scholar] [CrossRef]
  166. Wu, X.; Li, C.; Mariyam, Z.; Jiang, P.; Zhou, M.; Zeb, F.; Haq, I.U.; Chen, A.; Feng, Q. Acrolein-Induced Atherogenesis by Stimulation of Hepatic Flavin Containing Monooxygenase 3 and a Protection from Hydroxytyrosol. J. Cell. Physiol. 2018, 234, 475–485. [Google Scholar] [CrossRef] [Green Version]
  167. Zhu, L.; Liu, Z.; Feng, Z.; Hao, J.; Shen, W.; Li, X.; Sun, L.; Sharman, E.; Wang, Y.; Liu, J.; et al. Hydroxytyrosol Protects against Oxidative Damage by Simultaneous Activation of Mitochondrial Biogenesis and Phase II Detoxifying Enzyme Systems in Retinal Pigment Epithelial Cells. J. Nutr. Biochem. 2010, 21, 1089–1098. [Google Scholar] [CrossRef]
  168. Xu, Y.; Wu, L.; Chen, A.; Xu, C.; Feng, Q. Protective Effects of Olive Leaf Extract on Acrolein-Exacerbated Myocardial Infarction via an Endoplasmic Reticulum Stress Pathway. Int. J. Mol. Sci. 2018, 19, 493. [Google Scholar] [CrossRef] [Green Version]
  169. Crupi, R.; Palma, E.; Siracusa, R.; Fusco, R.; Gugliandolo, E.; Cordaro, M.; Impellizzeri, D.; De Caro, C.; Calzetta, L.; Cuzzocrea, S.; et al. Protective Effect of Hydroxytyrosol Against Oxidative Stress Induced by the Ochratoxin in Kidney Cells: In Vitro and in Vivo Study. Front. Vet. Sci. 2020, 7, 136. [Google Scholar] [CrossRef] [Green Version]
  170. Mohan, V.; Das, S.; Rao, S.B.S. Hydroxytyrosol, a Dietary Phenolic Compound Forestalls the Toxic Effects of Methylmercury-Induced Toxicity in IMR-32 Human Neuroblastoma Cells. Environ. Toxicol. 2016, 31, 1264–1275. [Google Scholar] [CrossRef]
  171. Officioso, A.; Panzella, L.; Tortora, F.; Alfieri, M.L.; Napolitano, A.; Manna, C. Comparative Analysis of the Effects of Olive Oil Hydroxytyrosol and Its 5-S-Lipoyl Conjugate in Protecting Human Erythrocytes from Mercury Toxicity. Oxid. Med. Cell. Longev. 2018, 2018, 9042192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  172. Manna, C.; Napoli, D.; Cacciapuoti, G.; Porcelli, M.; Zappia, V. Olive Oil Phenolic Compounds Inhibit Homocysteine-Induced Endothelial Cell Adhesion Regardless of Their Different Antioxidant Activity. J. Agric. Food Chem. 2009, 57, 3478–3482. [Google Scholar] [CrossRef] [PubMed]
  173. De Souza, P.A.L.; Marcadenti, A.; Portal, V.L. Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease. Nutrients 2017, 9, 1087. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The Hg biogeochemical cycle. Hg pollution of the environment mainly results from natural sources such as volcanic activity and fossil fuels as well as human industrial activities. Hg exists in the ecosystem in elementary, inorganic, and organic forms. These different species can be environmentally as well as biologically converted into each other in soil, air and especially water. In aquatic sediments, inorganic Hg is converted into its organic forms, mainly methylmercury, by microorganisms. This form enters the trophic network via plankton and it accumulates in the passage through small to carnivorous fish at the top of the food chain, via the process of biomagnification, reaching humans through contaminated fish.
Figure 1. The Hg biogeochemical cycle. Hg pollution of the environment mainly results from natural sources such as volcanic activity and fossil fuels as well as human industrial activities. Hg exists in the ecosystem in elementary, inorganic, and organic forms. These different species can be environmentally as well as biologically converted into each other in soil, air and especially water. In aquatic sediments, inorganic Hg is converted into its organic forms, mainly methylmercury, by microorganisms. This form enters the trophic network via plankton and it accumulates in the passage through small to carnivorous fish at the top of the food chain, via the process of biomagnification, reaching humans through contaminated fish.
Ijms 22 06604 g001
Figure 2. Mechanisms of toxicity associated with Hg exposure, most of which lead to oxidative stress.
Figure 2. Mechanisms of toxicity associated with Hg exposure, most of which lead to oxidative stress.
Ijms 22 06604 g002
Figure 3. Hg-induced procoagulant activity in RBC. Hg-induced PS exposure on the outer surface of RBC enhances RBC adhesion to the endothelial cells. Moreover, PS-bearing RBC and MVs provide a site for assembling the prothrombinase complex, leading to thrombin generation and clot formation.
Figure 3. Hg-induced procoagulant activity in RBC. Hg-induced PS exposure on the outer surface of RBC enhances RBC adhesion to the endothelial cells. Moreover, PS-bearing RBC and MVs provide a site for assembling the prothrombinase complex, leading to thrombin generation and clot formation.
Ijms 22 06604 g003
Figure 4. Morphological analysis of Hg-exposed RBC. Confocal Laser Scanning microscope imaging of intact RBC incubated in vitro in the presence of 20 μM HgCl2. At the end of incubation, cells were stained with Annexin V-FITC. (A) Untreated RBC; (B) HgCl2-treated RBC. Unpublished photos.
Figure 4. Morphological analysis of Hg-exposed RBC. Confocal Laser Scanning microscope imaging of intact RBC incubated in vitro in the presence of 20 μM HgCl2. At the end of incubation, cells were stained with Annexin V-FITC. (A) Untreated RBC; (B) HgCl2-treated RBC. Unpublished photos.
Ijms 22 06604 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Notariale, R.; Infantino, R.; Palazzo, E.; Manna, C. Erythrocytes as a Model for Heavy Metal-Related Vascular Dysfunction: The Protective Effect of Dietary Components. Int. J. Mol. Sci. 2021, 22, 6604. https://doi.org/10.3390/ijms22126604

AMA Style

Notariale R, Infantino R, Palazzo E, Manna C. Erythrocytes as a Model for Heavy Metal-Related Vascular Dysfunction: The Protective Effect of Dietary Components. International Journal of Molecular Sciences. 2021; 22(12):6604. https://doi.org/10.3390/ijms22126604

Chicago/Turabian Style

Notariale, Rosaria, Rosmara Infantino, Enza Palazzo, and Caterina Manna. 2021. "Erythrocytes as a Model for Heavy Metal-Related Vascular Dysfunction: The Protective Effect of Dietary Components" International Journal of Molecular Sciences 22, no. 12: 6604. https://doi.org/10.3390/ijms22126604

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop